Hollis, Sally
AstraZeneca,
United Kingdom
2025 Rank: 71250
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Arthritis & Rheumatology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 484 out of 43105 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 71250 | 80700 |
| Total Cites | 7747 | 8283 |
| H-index | 44 | 46 |
| Hm-index | 17 | 17 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 194 | 196 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 2113 | 2144 |
| Number of Single+First+Last Authored Papers | 33 | 33 |
| Total Cites to Single+First+Last Authored Papers | 3523 | 3635 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7417 | 7803 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.06 |
| Self-Citation Percentage |
6.47%
|
|
Hollis, Sally
AstraZeneca,
United Kingdom
2024 Rank: 67517
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General & Internal Medicine
SubField 2:
Arthritis & Rheumatology
Rank in SubField 1: 855 out of 333256 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 67517 | 76732 |
| Total Cites | 7477 | 7986 |
| H-index | 44 | 46 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 186 | 188 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 2053 | 2084 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 3372 | 3463 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7165 | 7530 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.06 |
| Self-Citation Percentage |
6.37%
|
|
Hollis, Sally
AstraZeneca,
United Kingdom
2023 Rank: 63218
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General & Internal Medicine
SubField 2:
Arthritis & Rheumatology
Rank in SubField 1: 823 out of 321279 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 63218 | 72156 |
| Total Cites | 7238 | 7754 |
| H-index | 44 | 46 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 181 | 183 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 1984 | 2014 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 3303 | 3408 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6933 | 7306 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.06 |
| Self-Citation Percentage |
6.65%
|
|
Hollis, Sally
AstraZeneca,
United Kingdom
2022 Rank: 58605
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General & Internal Medicine
SubField 2:
Arthritis & Rheumatology
Rank in SubField 1: 769 out of 311132 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 58605 | 67454 |
| Total Cites | 6904 | 7393 |
| H-index | 43 | 45 |
| Hm-index | 16 | 16 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 178 | 180 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 1899 | 1929 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 3165 | 3269 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6603 | 6958 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.06 |
| Self-Citation Percentage |
6.61%
|
|
Hollis, Sally
PHASTAR,
United Kingdom
2021 Rank: 57073
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General & Internal Medicine
SubField 2:
Arthritis & Rheumatology
Rank in SubField 1: 643 out of 224174 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57073 | 64959 |
| Total Cites | 6693 | 7172 |
| H-index | 41 | 44 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 177 | 179 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 1835 | 1865 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 3092 | 3199 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6404 | 6751 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.06 |
| Self-Citation Percentage |
6.68%
|
|
Hollis, Sally
PHASTAR,
United Kingdom
2020 Rank: 52943
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General & Internal Medicine
SubField 2:
Arthritis & Rheumatology
Rank in SubField 1: 492 out of 106795 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52943 | 60980 |
| Total Cites | 6355 | 6818 |
| H-index | 40 | 42 |
| Hm-index | 16 | 16 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 172 | 174 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 1745 | 1775 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 2962 | 3069 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6072 | 6404 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.06 |
| Self-Citation Percentage |
6.79%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.